19-33302352-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004364.5(CEBPA):āc.63C>Gā(p.Ser21Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000373 in 1,340,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S21I) has been classified as Uncertain significance.
Frequency
Consequence
NM_004364.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEBPA | NM_004364.5 | c.63C>G | p.Ser21Arg | missense_variant | 1/1 | ENST00000498907.3 | |
CEBPA | NM_001287424.2 | c.168C>G | p.Ser56Arg | missense_variant | 1/1 | ||
CEBPA | NM_001287435.2 | c.21C>G | p.Ser7Arg | missense_variant | 1/1 | ||
CEBPA | NM_001285829.2 | c.-295C>G | 5_prime_UTR_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEBPA | ENST00000498907.3 | c.63C>G | p.Ser21Arg | missense_variant | 1/1 | NM_004364.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151464Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000336 AC: 4AN: 1189140Hom.: 0 Cov.: 32 AF XY: 0.00000692 AC XY: 4AN XY: 578036
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151464Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73974
ClinVar
Submissions by phenotype
Acute myeloid leukemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jun 11, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 21 of the CEBPA protein (p.Ser21Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at